T1	intervention 12 33	topical lotion, CG428
T2	eligibility 532 564	Breast cancer patients with PCIA
T4	location 512 530	Seoul, South Korea
T6	control 848 855	placebo
T8	total-participants 1074 1076	35
T9	intervention-participants 1123 1125	18
T10	control-participants 1143 1145	17
T11	age 1227 1246	52.1 vs. 41.6 years
T12	outcome 1264 1298	mean hair density (SD) at baseline
T15	outcome 1435 1449	hair thickness
T18	outcome 1516 1528	hair density
T19	outcome 1506 1514	6 months
T20	iv-cont-mean 1546 1550	34.7
T21	cv-cont-mean 1555 1560	24.9%
T22	outcome 1674 1688	hair thickness
T23	iv-cont-mean 1694 1698	19.8
T24	cv-cont-mean 1703 1708	35.6%
T3	iv-cont-mean 1303 1307	97.6
T5	iv-cont-sd 1309 1312	6.4
T13	cv-cont-mean 1318 1323	126.8
T14	cv-cont-sd 1325 1329	30.3
T16	iv-cont-mean 1455 1459	49.9
T25	iv-cont-sd 1461 1465	12.7
T17	cv-cont-mean 1471 1475	48.1
T26	cv-cont-sd 1477 1480	8.4
